Clinical Trials Logo
  1. Home
  2. Anal Carcinoma
  3. NCT02369939

Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy — HYCAN  

Anal Carcinoma Clinical Trial

Official title:
Randomized Trial to Evaluate Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy

Clinical Trial Summary

Randomized study to investigate the efficacy of deep regional hyperthermia in patients with anal carcinoma treated by standard radiochemotherapy with MMC and 5-FU.

Clinical Trial Description

Pat. with anal carcinoma and treated with standard radiochemotherapy with Mitomycin C and 5-FU will in the experimental arm receive deep regional hyperthermia (6x). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02369939
Study type Interventional
Source University of Erlangen-Nürnberg Medical School
Contact Rainer Fietkau, Prof. Dr.
Phone ++49(0)9131-85
Email st-studiensekretatiat@uk-erlangen.de
Status Recruiting
Phase Phase 3
Start date December 2014
Completion date April 2021
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02408861 - Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery Phase 1
Recruiting NCT05663502 - Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Active, not recruiting NCT00867464 - Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls
Active, not recruiting NCT04272034 - Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors Phase 1
Recruiting NCT05787535 - HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor Phase 1
Active, not recruiting NCT04505553 - Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer Phase 2
Active, not recruiting NCT04230759 - Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group Phase 2
Active, not recruiting NCT04713618 - Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy
Recruiting NCT05438836 - Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer
Completed NCT00423254 - Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. Phase 1
Recruiting NCT02628067 - Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) Phase 2
Recruiting NCT01877135 - Malignant Progression of Anal Intra-epithelial Neoplasia in a Cohort of Patients N/A
Recruiting NCT03241680 - Study of Anal Cytologies in Patients With High Grade Cervical Intraepithelial Neoplasia (CIN II and III) N/A
Active, not recruiting NCT02816879 - Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men N/A
Recruiting NCT04802876 - Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors Phase 2
Completed NCT03469596 - Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor?